- €4.63bn
- €5.41bn
- €1.15bn
- 83
- 22
- 79
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.5 | ||
| PEG Ratio (f) | 2.07 | ||
| EPS Growth (f) | 12.84% | ||
| Dividend Yield (f) | 1.04% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.01 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 23.32 | ||
| Price to Sales | 4.03 | ||
| EV to EBITDA | 15.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.48% | ||
| Return on Equity | 10.46% | ||
| Operating Margin | 18.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 706.32 | 881.3 | 1,237.65 | 1,361.14 | 1,148.21 | 1,177.34 | 1,269.76 | 11.4% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +12.46 | +40.21 | +24.3 | -18.84 | -31.37 | +10.76 | +17.53 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Directors
- Gustavo Denegri NEC (84)
- Carlo Rosa CEO (55)
- Michele Denegri NVC (52)
- Piergiorgio Pedron CFO (50)
- John Gerace CEX
- Stefano Ronchi SVP (61)
- Ugo Gay SVP (56)
- Chen Even EDR (58)
- Giuseppe Alessandria LED (78)
- Stefano Altara NED (53)
- Giancarlo Boschetti NED (81)
- Luca Melindo NED (50)
- Fiorella Altruda IND (68)
- Elisa Corghi IND (49)
- Franco Moscetti IND (69)
- Francesca Pasinelli IND (61)
- Roberta Somati IND (52)
- Monica Tardivo IND (51)
- Tullia Todros IND (72)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 1970
- Public Since
- July 19th, 2007
- No. of Employees
- 3,233
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Borsa Italiana- Shares in Issue
- 53,359,979
- Address
- via Crescentino snc, SALUGGIA, 13040
- Web
- https://www.diasorin.com/
- Phone
- +39 0161487526
- Contact
- Riccardo Fava
- Auditors
- PricewaterhouseCoopers SpA
Latest News for DIA
Upcoming Events for DIA
DiaSorin SpA Annual Shareholders Meeting
DiaSorin SpA Annual Shareholders Meeting
Q1 2024 DiaSorin SpA Earnings Release
Dividend For DIAS.MI - 1.1500 EUR
Half Year 2024 DiaSorin SpA Earnings Release
Similar to DIA
Amplifon SpA
Borsa Italiana
El En SpA
Borsa Italiana
Gvs SpA
Borsa Italiana
IMD International Medical Devices SpA
Borsa Italiana
Ivision Tech SPA
Borsa Italiana
FAQ
As of Today at 19:06 UTC, shares in DiaSorin SpA are trading at €86.70. This share price information is delayed by 15 minutes.
Shares in DiaSorin SpA last closed at €86.70 and the price had moved by -12.51% over the past 365 days. In terms of relative price strength the DiaSorin SpA share price has underperformed the FTSE Global All Cap Index by -19.3% over the past year.
The overall consensus recommendation for DiaSorin SpA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
DiaSorin SpA does not currently pay a dividend.
DiaSorin SpA does not currently pay a dividend.
DiaSorin SpA does not currently pay a dividend.
To buy shares in DiaSorin SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €86.70, shares in DiaSorin SpA had a market capitalisation of €4.63bn.
Here are the trading details for DiaSorin SpA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: DIA
Based on an overall assessment of its quality, value and momentum DiaSorin SpA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in DiaSorin SpA is €95.90. That is 10.61% above the last closing price of €86.70.
Analysts covering DiaSorin SpA currently have a consensus Earnings Per Share (EPS) forecast of €3.51 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DiaSorin SpA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -7.25%.
As of the last closing price of €86.70, shares in DiaSorin SpA were trading -3.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The DiaSorin SpA PE ratio based on its reported earnings over the past 12 months is 23.5. The shares last closed at €86.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
DiaSorin SpA's management team is headed by:
- Gustavo Denegri - NEC
- Carlo Rosa - CEO
- Michele Denegri - NVC
- Piergiorgio Pedron - CFO
- John Gerace - CEX
- Stefano Ronchi - SVP
- Ugo Gay - SVP
- Chen Even - EDR
- Giuseppe Alessandria - LED
- Stefano Altara - NED
- Giancarlo Boschetti - NED
- Luca Melindo - NED
- Fiorella Altruda - IND
- Elisa Corghi - IND
- Franco Moscetti - IND
- Francesca Pasinelli - IND
- Roberta Somati - IND
- Monica Tardivo - IND
- Tullia Todros - IND